Good clinical practice regulatory inspections: Lessons for Indian investigator sites
2010

Lessons from Clinical Trial Inspections in India

publication

Author Information

Author(s): Marwah R., Van de Voorde K., Parchman J.

Primary Institution: Bristol-Myers Squibb Company

Conclusion

Regulatory inspections are crucial for ensuring the integrity of clinical trial data and protecting patient safety.

Supporting Evidence

  • Regulatory inspections evaluate the integrity of data submitted to health authorities.
  • Common findings during inspections include protocol noncompliance and inadequate records.
  • FDA has increased the number of inspections conducted outside the US, including in India.

Takeaway

This study talks about how inspections of clinical trials help make sure that everything is done safely and correctly, especially in India where many trials are happening.

Digital Object Identifier (DOI)

10.4103/2229-3485.71776

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication